These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
5. [Simvastatin]. Burgmer U; Mohr K Dtsch Med Wochenschr; 1996 Jun; 121(23):769-70. PubMed ID: 8646995 [No Abstract] [Full Text] [Related]
6. Myoglobinuric renal failure due to long-standing lovastatin therapy in a patient with pre-existing chronic renal insufficiency. Biesenbach G; Janko O; Stuby U; Zazgornik J Nephrol Dial Transplant; 1996 Oct; 11(10):2059-60. PubMed ID: 8918723 [No Abstract] [Full Text] [Related]
7. Side effects of statins--prevalence, relevance, consequences. Sinzinger H Wien Klin Wochenschr; 2002 Nov; 114(21-22):887-8. PubMed ID: 12528318 [No Abstract] [Full Text] [Related]
8. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. Landesman KA; Stozek M; Freeman NJ Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341 [TBL] [Abstract][Full Text] [Related]
9. An overview: long-term tolerability of lovastatin and simvastatin. Bilheimer DW Zhonghua Yi Xue Za Zhi (Taipei); 1992 Feb; 49(2):138-9. PubMed ID: 1315197 [No Abstract] [Full Text] [Related]
10. [Hepatitis associated with treatment with lovastatin. Presentation of 2 cases]. Bruguera M; Joya P; Rodés J Gastroenterol Hepatol; 1998 Mar; 21(3):127-8. PubMed ID: 9607293 [TBL] [Abstract][Full Text] [Related]
11. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase]. Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616 [TBL] [Abstract][Full Text] [Related]
12. Statins and male hypogonadism. Cohen PG J Sex Med; 2011 Jun; 8(6):1826. PubMed ID: 21492398 [No Abstract] [Full Text] [Related]
13. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias]. Carmena R Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284 [No Abstract] [Full Text] [Related]
14. Skin lesions due to treatment with simvastatin (Zocor). Feldmann R; Mainetti C; Saurat JH Dermatology; 1993; 186(4):272. PubMed ID: 8513195 [No Abstract] [Full Text] [Related]
15. Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy. Manson JM; Freyssinges C; Ducrocq MB; Stephenson WP Reprod Toxicol; 1996; 10(6):439-46. PubMed ID: 8946557 [TBL] [Abstract][Full Text] [Related]
17. [Statin-induced Parkinson's-syndrome. Reader's letter on the article by J. Finsterer in "Der Nervenarzt" (2003) 74:115-122]. Müller T Nervenarzt; 2003 Aug; 74(8):726-7. PubMed ID: 12904874 [No Abstract] [Full Text] [Related]
18. Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome. Chariot P; Abadia R; Agnus D; Danan C; Charpentier C; Gherardi RK Am J Med; 1993 Jan; 94(1):109-10. PubMed ID: 8420287 [No Abstract] [Full Text] [Related]
19. Transient symptomatic hypotension in patients on simvastatin. French J; White H Lancet; 1989 Sep; 2(8666):807-8. PubMed ID: 2571051 [No Abstract] [Full Text] [Related]
20. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias. Aronson JK; Ng LL Q J Med; 1990 Feb; 74(274):111-5. PubMed ID: 2111916 [No Abstract] [Full Text] [Related] [Next] [New Search]